Font Size:

2021 ALERT HAN Messages

Table of Contents

View the ADPH HAN Alert Archives.

ADPH ALERT Messages

12/30/2021
FDA Issues Emergency Use Authorization for Paxlovid to Treat COVID-19 Infection

12/30/2021
Monoclonal Antibody Update: Effectiveness Against COVID-19 Omicron Variant

12/28/2021
COVID-19 Update for Hospitals and Healthcare Personnel

12/20/2021
COVID-19 omicron variant may negatively affect the test results of currently used COVID-19 tests

11/03/2021
CDC Recommends Pediatric COVID-19 Vaccine for Children 5 through 11 Years Old

10/22/2021
CDC Expands Eligibility for COVID-19 Vaccine Booster Shots

09/29/2021
Clarification on Physician Order and mRNA Vaccine Attestation For Use
COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19

09/24/2021
FDA Authorizes Pfizer's COVID-19 Booster for People Over 65 or at High Risk

09/15/2021
Immediate Change to HHS' COVID-19 Monoclonal Antibody Ordering Process

09/08/2021
COVID-19 Update on Availability of Monoclonal Antibody Treatment

09/01/2021
Sexually Transmitted Infection Treatment Guidelines, 2021

08/25/2021
Warning Issued by Federal Drug Administration (FDA) and World Health Organization (WHO) on Use of Ivermectin

08/24/2021
FDA Approves COMIRNATY (COVID-19 vaccine, mRNA) Previously Known as Pfizer-NTech

08/23/2021
COVID-19 Vaccination for Pregnant Individuals

08/16/2021
3rd Dose mRNA COVID-19 Vaccine in Immunocompromised and Use of Monoclonal Antibodies for High Risk Patients/Additional 3rd Dose of Pfizer or Moderna COVID-19 Vaccine for Immunocompromised

08/05/2021
Alabama Hospital Emergency Rooms Seeing Patient Surge

07/28/2021
COVID-19 Masking Update and the Delta Variant

07/22/2021
COVID-19 Update on Testing, Sequencing and Non-hospitalized Patient Treatment

05/13/2021
ADPH Calls for Children and Teens age 12 and up to get the COVID-19 Vaccine

04/30/2021
Providers Resume Use of the J&J/Janssen COVID-19 Vaccine

04/15/2021
ACIP Requests Continued Pause on Use of J & J Vaccine

04/13/2021
CDC and FDA Request Pause on Use of J & J Vaccine

03/23/2021
Increase in Perinatal HIV Cases in Alabama

02/19/2021
Updated Alabama Department of Public Health COVID-19 Non-Healthcare Isolation and Quarantine Guidance

01/29/2021
A Devastating Surge in Congenital Syphilis in Alabama

01/27/2021
Updated Gonorrhea Treatment Recommendations

CDC ALERT HAN Messages

12/31/2021
Using Therapeutics to Prevent and Treat COVID-19

12/24/2021
Rapid Increase of Omicron Variant Infections in the United States: Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure

12/01/2021
New SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant

11/24/2021
Increasing Seasonal Influenza A (H3N2) Activity, Especially Among Young Adults and in College and University Settings, During SARS-CoV-2 Circulation

11/05/2021
Update: Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results

11/03/2021
Source Identified and Case Definition Established: Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas – 2021

10/22/2021
Source Implicated in Fatal Case in Georgia: Multistate Outbreak of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas –2021

10/22/2021
Pfizer-BioNTech, Moderna, and Janssen COVID-19 Vaccine Booster Dose Recommendations

10/14/2021
Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results

09/29/2021
COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19

09/20/2021
Guidance for Clinicians Caring for Individuals Recently Evacuated from Afghanistan

09/14/2021
Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events

08/28/2021
Hurricane Ida—Clinical Guidance for Carbon Monoxide (CO) Poisoning

08/26/2021
Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19

08/09/2021
New Case Identified: Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas—2021

07/27/2021
Vaccination to Prevent COVID-19 Outbreaks with Current and Emergent Variants — United States, 2021

07/17/2021
Potential Exposure to Person with Confirmed Human Monkeypox Infection — United States, 2021

07/06/2021
Recall of LeadCare® Blood Lead Tests Due to Risk of Falsely Low Results

06/30/2021
Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Three Patients: Kansas, Texas, and Minnesota—2021

06/10/2021
Increased Interseasonal Respiratory Syncytial Virus (RSV) Activity in Parts of the Southern United States

04/13/2021
Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine

03/31/2021
Acute Non-Viral Hepatitis of Unknown Etiology Potentially Associated with an Alkaline Water Product

02/17/2021
2021 Winter Storms—Clinical Guidance for Carbon Monoxide (CO) Poisoning

02/12/2021
Extensively Drug-Resistant Salmonella Typhi Infections Among U.S. Residents Without International Travel





Page last updated: May 20, 2024